Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S Coffey

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Stroke|January 10, 2015
You may have worked on more adaptive designs than you thinkChristopher S Coffey
Statistics in Medicine|July 23, 2003
Properties of internal pilots with the univariate approach to repeated measuresChristopher S Coffey, Keith E Muller
The Lancet. Neurology|September 19, 2019
Antisense oligonucleotides might change the therapeutic landscape for Huntington's diseaseJane S Paulsen, Christopher S Coffey
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 2, 2002
Two-stage testing in microarray analysis: what is gained?David B Allison, Christopher S Coffey
Neurology|April 15, 2009
Stroke trials: a shift to shift analysis?Devin L Brown, Christopher S Coffey
Communications in Statistics: Theory and Methods|January 28, 2014
Properties of Doubly-Truncated Gamma VariablesChristopher S Coffey, Keith E Muller
Drugs in R&D|July 1, 2008
Adaptive clinical trials: progress and challengesChristopher S Coffey, John A Kairalla
Communications in Statistics: Theory and Methods|December 6, 2013
Some Distributions and Their Implications for an Internal Pilot Study With a Univariate Linear ModelChristopher S Coffey, Keith E Muller
Clinical Trials (London, England)|February 5, 2013
Monitoring futility in a two-by-two factorial design: the SPS3 experienceLeslie A McClure, Christopher S Coffey, George Howard
Stroke|June 11, 2005
Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirensGeorge Howard, Christopher S Coffey, Gary R Cutter
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Stroke|January 10, 2015
You may have worked on more adaptive designs than you thinkChristopher S Coffey
Statistics in Medicine|July 23, 2003
Properties of internal pilots with the univariate approach to repeated measuresChristopher S Coffey, Keith E Muller
The Lancet. Neurology|September 19, 2019
Antisense oligonucleotides might change the therapeutic landscape for Huntington's diseaseJane S Paulsen, Christopher S Coffey
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 2, 2002
Two-stage testing in microarray analysis: what is gained?David B Allison, Christopher S Coffey
Neurology|April 15, 2009
Stroke trials: a shift to shift analysis?Devin L Brown, Christopher S Coffey
Communications in Statistics: Theory and Methods|January 28, 2014
Properties of Doubly-Truncated Gamma VariablesChristopher S Coffey, Keith E Muller
Drugs in R&D|July 1, 2008
Adaptive clinical trials: progress and challengesChristopher S Coffey, John A Kairalla
Communications in Statistics: Theory and Methods|December 6, 2013
Some Distributions and Their Implications for an Internal Pilot Study With a Univariate Linear ModelChristopher S Coffey, Keith E Muller
Clinical Trials (London, England)|February 5, 2013
Monitoring futility in a two-by-two factorial design: the SPS3 experienceLeslie A McClure, Christopher S Coffey, George Howard
Stroke|June 11, 2005
Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirensGeorge Howard, Christopher S Coffey, Gary R Cutter
Pageof 17